Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

MHRA joins Instagram as part of Yellow Card drive

UK medicines regulator follows in the footsteps of NICE in using the channel

MHRA Instagram

The MHRA has increased its use of social media for its latest campaign to encourage the public to report any suspected side effects from taking over-the-counter medicines.

In joining Instagram, where it is @mhragovuk, the MHRA follows in the footsteps of England and Wales’ HTA body NICE (@nicecomms), which launched on the channel at the beginning of this month.

NICE has focused on AMR and diabetes to date, while the UK medicines regulator has so far been using Instgram to encourage the use of its Yellow Card scheme.

All regulatory reporting systems suffering from under-reporting and the MHRA hopes that its latest campaign will “both raise awareness and help strengthen the system”.

Mick Foy, group manager for MHRA’s Vigilance and Risk Management of Medicines division, said: “our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”

The MHRA’s social media campaign, of which its new Instagram account is just one element, is part of Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE), a joint action project funded by the European Union.

22nd November 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics